JAM-A (N-Term) Rabbit Monoclonal

Confirm delete?

JAM-A (N-Term) Rabbit Monoclonal Antibody

Zoom

Cat No: 32225

Junctional adhesion molecule A (JAM-A), known previously as JAM-1, is a type I transmembrane protein and member of the immunoglobulin (Ig) superfamily that regulates epithelial and endothelial barrier and tight junction formation.{59625,59626,59627} I...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

JAMA Nterm JAM 1 Nterminal JAMB JAMC ?L? 2 ?M? 2 ?4? 1

Product Overview:
Junctional adhesion molecule A (JAM-A), known previously as JAM-1, is a type I transmembrane protein and member of the immunoglobulin (Ig) superfamily that regulates epithelial and endothelial barrier and tight junction formation.{59625,59626,59627} It is comprised of an N-terminal extracellular domain containing two Ig-like domains that mediate cell-cell interactions, a single transmembrane domain, and a cytoplasmic tail containing a PDZ binding motif that interacts with numerous cytoplasmic scaffold proteins and intracellular signaling molecules.{59625,59626} JAM-A exists as a monomer or homodimer, is primarily expressed by epithelial cells, endothelial cells, and leukocytes, and localizes to the cell surface.{59625} It associates via cis- or trans-interactions with a variety of cell surface proteins, including the additional JAM family members JAM-B and JAM-C, which are also expressed by epithelial cells, endothelial cells, and leukocytes, as well as integrins expressed by leukocytes, such as αLβ2, αMβ2, and α4β1, to mediate homotypic or heterotypic cell-cell adhesions that regulate tight junction assembly and transepithelial cell migration. JAM-A has additional roles in angiogenesis, hemostasis, cell cycle, and inflammation. JAM-A levels are increased in plasma cells isolated from patients with multiple myeloma and are associated with poor prognosis.{59628} Cayman's JAM-A (N-Term) Rabbit Monoclonal Antibody can be used for immunohistochemistry (IHC) and Western blot (WB) applications.

Size	100 µl
Shipping	dry ice
Host	Rabbit
Antigen	Peptide from the N-terminal region of human JAM-A
Clone	RM275
Isotype	IgG
Application(s)	IHC, WB
Formulation	100 µl of protein A-affinity purified monoclonal antibody
Custom Code	3822.19
UNSPSC code	12352203

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.